blogger delicious digg diigo facebook googleplus linkedin netlog reddit twitter
Skip Navigation LinksJRI > Archive > January-March 2000, Volume 1, Issue 1 > Genetics of Testicular Germ Cell Tumors



Volume 1, Issue 1, Number 1 / January-March
(pages 44-51)


Genetics of Testicular Germ Cell Tumors




 Corresponding Author
Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran


Related Articles
in Google Scholar in PubMed

 

Other Format
pdfPDF Full Text (En) pdfPDF Full Text (Fa) pdfePUB Full Text (En) pdfPDF Abstract (En) pdfPDF Abstract (Fa) pdf BibTeX pdfRefMan pdfEndNote xmlPMC XML online readerPMC Reader

 


Abstract
Testicular germ cell tumor (TGCT) is the most solid tumor in 20-40 years old man. TGCT account for 95% of testicular tumors and represent a unique type of human cancer from several different perspectives. TGCT arise by transformation of germ cells. The Transformed germ cells exhibit ploripotentially to differentiate into embryonic. Extra-embryonic, and somatic tissue types, and are highly sensitive to cisplatin-based chemotherapy. Investigation into the genetics of TGCT can provide methods of molecular diagnosis and help to the understanding of molecular basis of transformation, differentiation and sensitivity/resistance . The molecular basis for the chemosensitivity of these tumors is poorly understood, although initial stadies suggest that wild-type p53 might play a central role, further studies will provide insights into why other other solid tumors remain far from curable. The following review will provide information about genetic altration and chromosomal aberration occur in TGCT. These studies have identified multiplication of 12p, manifested in 1 (12p) or tandem duplication of 12p, As a unique change in TGCT which serves as a diagnostic marker. These data also indicate that multiple genetic events play a role in distinct pathways in the development of TGCT, and further elucidation of the underlying genetic and biochemical mechanisms is central to unraveling biology and improving treatment of TGCT.

Keywords:


To cite this article:


References
  1. Mostofi FK, Spaander P, Gingor K. Cousensus on pathological clasihication of testicular germ cell tumors. Prog. Clin. Biol. Res: 357(1990),267-276.
  2. Lutzher and Brenard/1998.
  3. Skakkebaek N, Possible carcinoma in situ of the testis Haucet: 2(1972),516-517.
  4. Chaganti RSK, Rodrigues E, Mathew S. Origin of adult male mediastinal germ-cell tumors. Loucet: 343(1994), 1130-1132.
  5. De Joug B, et al. Pathogenesis of adult testicular germ cell tumors. A cylogenic model. Cytogenet-Cell Genet: 48(1990), 1443-167.
  6. Aktin, N and Baker M. Specific chromosome change in testicular tumors? Houcet: 11(1982), 1349.
  7. Rajpert-De Myts E, et al. Development arrest of germ cells in the pathogenesis of germ cell neoplasic. APMIS: 166(1998)198-204.
  8. Bosl G, et al. Clinical relevance of the I (12p) marker chromosome in germ cell tumors. J. Natl. Cancer Inst: 5(1994), 349-355.
  9. Korn W, et al. Detection of chromosomal DNA gains and losses in testicular germ cell tumors by
  10. Bishop T.D, Candidate regions for Testicular cancer susceptibility genes. APMIS Suppl: 106(1998),64-72.
  11. Chagani R.S.K., & Houldsworth J. The cytogenetic theory of pathogenesis of human adult male germ cell tumours, Review article, AMPIS: 106(1998), 80-84.
  12. Leahy M.G. Tonks S., Moses J.H., Brett, A.R., Huddart R., Forman D., Oliver R.T.D., Bishop D.T., & Bodmer, J.G. Candidate regions for a testicular cancer susceptibility gene, HMG: 4(9)(1995), 1551-1555.
  13. Looijenga L.H., Abraham M., Gillis A.J.W. Testicular germ cell tumors of adults shows deletions of chromosomal bands 11p13 and 11p15.5, but no abnormalities within the zinc-finger regions and exons 2 and 6 of the Wilms tumor 1 gene, Genes Chromosomes Cancer: 9(3)(1994), 153-60(Abstract).
  14. Lothe R.A., Hastie N., Heimdal K., Fossa S.D., Stenwi A.E., Borresen A.L. Frequent loss of 11p13 and 11p15 loci in male germ cell tumours, Genes Chromosomes Cancer: 7(2)(1993),96-101(Abstract).
  15. Lutzker S.G., & Barnard N.J. testicular germ cell tumors: molecular understanding and clinical implications, Molecular Medicine Toady, September 1998:404-411.
  16. Sinke R.J., Van Asseldonk M., de Bruijn D., Strijk A., Merkx G., Olde Weghus D., de Jong B., Oosterhuis J.W., Geurts van Kessel A. Towards isolation of a human malignant extragonadal germ cell tumourassociated breakpoint in chromosome 11q13, APMIS:106(1)(1998),73-8 and 78-9(Abstract).
  17. Summersgill B., Goker H., Weber-Hall S., Huddart R., Horwich A., Shipley J. Molecular cytognetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy change, Br J Cancer: 77(2)(1998),305-13(Abstract).
  18. Wang X., Hafezparast M., & Masters J.R.W. Complementation Analysis of Tumour Cells, Cancer Genetics Cytogenet: 98(1997),56,62.
  19. Strohmeger T. Correction between retinoblastoma gene expression and differentiation in human testicular tumors. Proc. natl. Acad. Sci. USA.: (1991), 6662-6666.
  20. Peng HA. Loss of heterozyposity of tumor suppressor genes in testis caucer. Cancer Res: 55(1995),2871-2875.
  21. Houldsworth J., reuter V., Bosl G., and Chagati R. Aberrant expression of cyclin D2 is an early event in human male gem cell tumorigenesis. Cell Growth Differ: 89(1997),293-299.
  22. Sienski P. Cyclin D2 is an FSH-respensive gene involved in gonadal cell proliferation and on cogenesis. Natare:384(1996),470-474.
  23. Chong F., S., and Syrjaene K. Implicadious of the P53 tumor suppressor gene in clinical oncology. J Clin. Oncol: 13(1995),1009-1022.
  24. Peng H.Q. Mutations of the P53 gene do not occur in testis concers., Cancer Res: 53(1993);3574-3578.
  25. Heimdal K. No germline TP53 mutations detected in familia and bilateral testicular concers. Genes Chromosomes Cancer: 6 ( ) 92-97.
  26. Schenkman N, et al. Increased p53 protein does not correlates to p 53 gene mutations in microdissected human testicular gem cell tumors J. Urol: 154 (1995),617-621.
  27. Lowe S.E, et al p53 status and the efficacy of cancer therapy in vivo. Scieence: 266 (1994), 807-810.
  28. Chresta C.M., Masters J.R.D. and Hickman J.A Hyperapoptosis is associated with functional p53 and a high bax: bcl-2 ratio. Cancer Res: 56(1996),1834.
  29. Leathy et al . 1995.
  30. Blough RI, Vance GH, Henegariu O, Smolareck TA, Sledge Jr, G.W., & N.A. Characterization of Multiple 12p Rearrangements in Testicular Germ Cell Tumor Cell Line 833 K and Its Subcllone, 64CP by Chromosome Microdissection. Cancer Genet Cytogenet: 106(1998), 24-29.
  31. Ottense A.M., Kirchhoff M., De-Meyts E.R., Maahr J., gerdes T., Rose H., Lundsteen C., Petersen P.M., Philip j., Shakebeak N.E. Detection of chromosomal aberrations in seminomatous germ cell tumours using comparative genomic hybridization, Genes Chromosome Cancer: 20(4)(1997), 412-8(Abstract).



Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and copyrighted by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2016 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.